Clinical characteristics, prognosis and treatment of myelofibrosis patients with severe thrombocytopenia.

Hernández-Boluda, Juan-CarlosCorrea, Juan-GonzaloAlvarez-Larrán, AlbertoFerrer-Marín, FranciscaRaya, José-MaríaMartínez-López, JoaquínVelez, PatriciaPérez-Encinas, ManuelEstrada, NataliaGarcía-Gutiérrez, ValentínFox, María-LauraLuño, ElisaKerguelen, AnaCuevas, BeatrizDurán, María-AntoniaRamírez, María-JoséGómez-Casares, MaiteMata-Vázquez, María-IsabelRegadera, AnabelPereira, ArturoCervantes, FranciscoGrupo Español de Enfermedades Mieloproliferativas Filadelfia Negativas (GEMFIN)2023-01-252023-01-252017-04-17http://hdl.handle.net/10668/11106enbleedingmyelofibrosisprognosisthrombocytopeniatreatmentAgedDisease-Free SurvivalFemaleHumansMaleMiddle AgedPrimary MyelofibrosisRegistriesSpainSurvival RateThrombocytopeniaClinical characteristics, prognosis and treatment of myelofibrosis patients with severe thrombocytopenia.research article28419426open access10.1111/bjh.146011365-2141https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.14601